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sensitive nicotinic acetylcholine receptors
Abstract
The ongoing and widespread emergence of resistance to the existing anti-nematodal pharmacopeia has made
it imperative to develop new anthelminthic agents. Historically, plants have been important sources of
therapeutic compounds and offer an alternative to synthetic drugs. Monoterpenoids are phytochemicals that
have been shown to produce acute toxic effects in insects and nematodes. Previous studies have shown
nicotinic acetylcholine receptors (nAChRs) to be possible targets for naturally occurring plant metabolites
such as carvacrol and carveol. In this study we examined the effects of monoterpenoid compounds on a
levamisole sensitive nAChR from Oesophagostomum dentatum and a nicotine sensitive nAChR from Ascaris
suum. We expressed the receptors in Xenopus laevis oocytes and used two-electrode voltage-clamp to
characterize the effect of various compounds on these cys-loop receptors. At 100 μM the majority of these
compounds acted as antagonists. Interestingly, further experiments revealed that both 0.1 μM and 10 μM
menthol potentiated acetylcholine and levamisole responses in the levamisole sensitive receptor but not the
nicotine sensitive receptor. We also investigated the effects of 0.1 μM menthol on the contractility of A. suum
somatic muscle strips. Menthol produced significant potentiation of peak contractions at each concentration
of acetylcholine. The positive allosteric modulatory effects of menthol in both in vivo and in vitro experiments
suggests menthol as a promising candidate for combination therapy with cholinergic anthelmintics.
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Abstract 12 
The ongoing and widespread emergence of resistance to the existing anti-nematodal 13 
pharmacopeia has made it imperative to develop new anthelminthic agents. Historically, 14 
plants have been important sources of therapeutic compounds and offer an alternative to 15 
synthetic drugs. Monoterpenoids are phytochemicals that have been shown to produce 16 
acute toxic effects in insects and nematodes. Previous studies have shown nicotinic 17 
acetylcholine receptors (nAChRs) to be possible targets for naturally occurring plant 18 
metabolites such as carvacrol and carveol. In this study we examined the effects of 19 
monoterpenoid compounds on a levamisole sensitive nAChR from Oesophagostomum 20 
dentatum and a nicotine sensitive nAChR from Ascaris suum. We expressed the receptors 21 
in Xenopus laevis oocytes and used two-electrode voltage-clamp to characterize the effect 22 
of various compounds on these cys-loop receptors. At 100 µM the majority of these 23 
compounds acted as antagonists. Interestingly, further experiments revealed that both 0.1 24 
µM and 10 µM menthol potentiated acetylcholine and levamisole responses in the 25 
levamisole sensitive receptor but not the nicotine sensitive receptor. We also investigated 26 
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the effects of 0.1 µM menthol on the contractility of A. suum somatic muscle strips. 27 
Menthol produced significant potentiation of peak contractions at each concentration of 28 
acetylcholine. The positive allosteric modulatory effects of menthol in both in vivo and in 29 
vitro experiments suggests menthol as a promising candidate for combination therapy with 30 
cholinergic anthelmintics.  31 
 32 
Keywords 33 
Menthol, allosteric modulation, nAChR, monoterpenoid, nematode 34 
 35 
Abbreviations  36 
Asu, Ascaris suum; BAPTA-AM, 1,2-bis(2-aminophenoxy)ethane-N,N,N′,N′-tetraacetic acid 37 
tetrakis (acetoxymethyl ester); cRNA, complementary RNA; DMSO, dimethyl sulfoxide; 38 
Hco, Haemonchus contortus; nAChR, nicotinic acetylcholine receptor; Ode, 39 
Oesophagustomum dentatum; PAM, positive allosteric modulator; STHs, soil transmitted 40 
helminths.  41 
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1. Introduction: 43 
Parasitic nematode infections are a threat to health and have significant socio-44 
economic consequences. Among the different classes of nematodes, soil transmitted 45 
helminths (STHs) are major contributors to the global parasite burden. According to WHO 46 
(2018) , more than 1.5 billion people, or 24% of the world’s population, are infected with at 47 
least one species of soil transmitted helminth, which mainly include Ascaris lumbricoides, 48 
Trichuris trichiura and hookworms (Necator americanus and Ancylostoma duodenale). 49 
These infections are most commonly found in tropical and sub-tropical countries due to 50 
suboptimal sanitation, lack of access to clean water and favorable climatic conditions for 51 
the parasites (Bethony et al., 2006; Brooker et al., 2006; Hotez et al., 2008; Savioli and 52 
Albonico, 2004). Although mortality is rare, high morbidity is a common feature of intestinal 53 
helminthiasis. The disease manifestations include weight loss, anemia, diarrhea, 54 
abdominal pain, malnutrition, general malaise, weakness, as well as impaired growth and 55 
physical development (Bethony et al., 2006). Children bear the highest burden of these 56 
infections which profoundly affect their physical growth, cognitive development and cause 57 
educational deficits (Alum et al., 2010; Brooker, 2010; Stephenson et al., 2000). STH 58 
infections such as Ascariasis have also been reported to exacerbate other diseases such 59 
as malaria, tuberculosis and HIV/AIDS (Fincham et al., 2003; Le Hesran et al., 2004).  In 60 
addition, production losses caused by intestinal nematodes of livestock have adverse 61 
effects on nutritional status and the food economy especially in poverty-stricken regions 62 
(Morgan et al., 2013). 63 
 64 
Effective vaccines are the most desirable approach but even after almost 30 years of 65 
dedicated research, a licensed vaccine against human parasites remains elusive. Current 66 
control strategies for treatment and prevention of helminth infections rely heavily on 67 
chemotherapy. Unfortunately, there are a limited number of classes of anthelmintic agents, 68 
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which include benzimidazoles, macrocyclic lactones and nicotinic agonists (Abongwa et 69 
al., 2017; Martin, 1997; Robertson and Martin, 2007). Moreover, widespread and 70 
indiscriminate administration combined with genetic factors has led to the development of 71 
resistance in animals (Albonico et al., 2003; Taman and Azab, 2014). There have also 72 
been reports of reduced therapeutic efficacy to anti-nematodal drugs in humans. De 73 
Clercq et al. (1997) and Flohr et al. (2007) reported poor efficacy of benzimidazoles 74 
against human hookworm infections. There is a need to focus research on drug discovery 75 
and development to overcome the issue of increasing resistance and reduced efficacy 76 
against existing drugs.  77 
 78 
The use of phytotherapeutics for parasitic infections has emerged as an attractive 79 
alternative. Plants have dominated the human pharmacopoeia for thousands of years 80 
(Balick and Cox, 1996; Newman and Cragg, 2016; Raskin and Ripoll, 2004). Many 81 
therapeutic products, including codeine, quinine, artemisinin, digitoxin, morphine, 82 
paclitaxel, galantamine, currently used in modern pharmacotherapy are of plant origin 83 
(Butler, 2004; Heinrich and Lee Teoh, 2004; Newman and Cragg, 2016; Newman et al., 84 
2000; Petrovska, 2012; Pirttila et al., 2004; Samuelsson, 2004). Plant based therapeutic 85 
compounds are environment-friendly and exhibit a wide array of medicinal properties 86 
(Balunas and Kinghorn, 2005; Coats, 1994; Dias et al., 2012; Harvey et al., 2015; Hu and 87 
Coats, 2008). Interestingly, an estimated four billion people living in the developing world 88 
rely on medicinal plants for their primary pharmaceutical care (WHO, 2005). Herbal 89 
remedies in the form of complementary and alternative medicine (CAM) are also being 90 
widely embraced in many developed countries (Anquez-Traxler, 2011; Calapai, 2008; 91 
Committee on the Use of Complementary, 2005). Among phytochemicals, essential oils 92 
and their active principles have been well documented for their broad range of functions 93 
including insecticidal and nematocidal activities (Camurca-Vasconcelos et al., 2007; Cetin 94 
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et al., 2009; Coskun et al., 2008; Enan, 2005; Macedo et al., 2009; Panella et al., 2005). 95 
Historically, thymol (found in oil of thyme), santonin (derived from buds of the local 96 
Artemisia spp.) and ascaridol (isolated from Chenopodium oil) were used in the late 97 
nineteenth and early twentieth century for the treatment of ascarids and hookworms in 98 
humans (Ferrell, 1914; Kaplan et al., 2014; Lamson and Ward, 1932). Terpene and 99 
terpenoid biomolecules, particularly monoterpenes and sesquiterpenes, found in essential 100 
oils have been identified as promising anthelmintic compounds and are of great 101 
pharmaceutical interest (Jaradat et al., 2016; Katiki et al., 2011; Lei et al., 2010; Pessoa et 102 
al., 2002; Squires et al., 2010). Lei et al. (2010) reported in vitro nematocidal activity of 103 
thymol and carvacrol (major components of thyme and oregano essential oils) 104 
against Caenorhabditis elegans and Ascaris suum. Trailović et al. (2015) also 105 
demonstrated the potential anthelmintic effects of carvacrol in A. suum.   106 
 107 
In the present study, we tested the activity of monoterpenoid compounds on two different 108 
nematode nAChR types: levamisole sensitive (L-type) nAChRs from Oesophagostomum 109 
dentatum and a nicotine sensitive (N-type) nAChR (ACR-16) from A. suum. The receptors 110 
were expressed in Xenopus laevis oocytes and we used two-electrode voltage-clamp to 111 
study the pharmacological effects of the compounds. We also investigated the effects of 112 
menthol on the contractility of A. suum somatic muscle strips. The focus of this study was 113 
to evaluate the effects produced by monoterpenoid compounds to identify potential 114 
alternatives to current chemotherapeutic agents. 115 
  116 
2. Materials and Methods  117 
2.1 cRNA preparation and X. laevis oocyte expression 118 
All nAChR subunit and ancillary factor cRNAs from O. dentatum (Ode-unc-29, Ode-unc-119 
38, Ode-unc-68 and Ode-acr-8), A. suum (Asu-acr-16 and Asu-ric-3) and Haemonchus 120 
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contortus (Hco-ric-3, Hco-unc-50 and Hco-unc-74) were prepared as previously described 121 
(Abongwa et al., 2016b; Buxton et al., 2014). The receptors were expressed in 122 
defolliculated X. laevis oocytes purchased from Ecocyte Bioscience (Austin, Texas, USA). 123 
N-type (nicotine sensitive) nAChRs from A. suum were expressed by co-injecting 25 ng 124 
of Asu-acr-16 with 5 ng of Asu-ric-3 in a total volume of 50 nL in nuclease-free 125 
water. Heteromeric (levamisole sensitive) nAChRs from O. dentatum were expressed by 126 
co-injecting 1.8 ng of each subunit cRNA (Ode-unc-29, Ode-unc-38, Ode-unc-68 and Ode-127 
acr-8) with 1.8 ng of each H. contortus ancillary factor (Hco-ric-3, Hco-unc-50 and Hco-128 
unc-74) in a total volume of 36 nL in nuclease-free water. The injections were made in the 129 
animal pole of the oocytes using a nanoject II microinjector (Drummond Scientific, 130 
Broomall, PA, USA). The injected oocytes were separated into 96-well plates containing 131 
200 µL incubation solution (100 mM NaCl, 2 mM KCl, 1.8 mM CaCl2.2H20, 1 mM 132 
MgCl2.6H20, 5 mM HEPES, 2.5 mM Na pyruvate, 100 U·mL−1 penicillin and 133 
100 µg·mL−1 streptomycin, pH 7.5); each well contained one oocyte. The solution was 134 
changed daily to maintain oocytes in optimal conditions. The oocytes were incubated at 19 135 
oC for at 5-7 days to allow functional expression of the receptor.  136 
 137 
2.2 Two-electrode voltage-clamp (TEVC) electrophysiology 138 
We used two-electrode voltage-clamp electrophysiology to record the inward current 139 
generated by the activation of expressed receptors in X. laevis oocytes. The oocytes were 140 
incubated with 100 µM BAPTA-AM (an intracellular calcium chelator) for ∼3 hours prior to 141 
recordings to prevent activation of endogenous calcium-activated chloride currents. The 142 
oocytes were clamped at -60mV for all the experiments with an Axoclamp 2B amplifier; all 143 
data were acquired on a desktop computer with Clampex 10.2 (Molecular Devices Inc., 144 
CA, USA). The microelectrodes used to impale oocytes were pulled using a 145 
Flaming/Brown horizontal micropipette puller (model P-97, Sutter Instruments Co., USA) 146 
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and filled with 3 M KCl. The tips of the microelectrodes were carefully broken with a tissue 147 
paper to achieve a resistance of 2-5 MΩ in recording solution (100 mM NaCl, 2.5 mM KCl, 148 
1 mM CaCl2·2H2O and 5 mM HEPES, pH 7.3). The low resistance allowed passage of 149 
large currents required to maintain adequate voltage-clamp of the oocyte. Oocytes were 150 
placed into a tiny groove of the narrow oocyte-recording chamber. The Digidata 1322A 151 
(Molecular Devices, CA, USA) was used to control the switches that controlled the 152 
perfusion of the chamber at a speed of ~6 mL/min. Un-injected oocytes served as the 153 
negative control. 154 
 155 
2.3 A. suum muscle flap contraction measurements 156 
The adult female A. suum worms were collected from the slaughterhouse at Surčin, 157 
Belgrade, Serbia and maintained at 32 °C in Locke’s solution (NaCl 155 mM, KCl 5 mM, 158 
CaCl2 2 mM, NaHCO3 1.5 mM and glucose 5 mM). The Locke’s solution was changed 159 
twice daily. Each batch of worms was used within 4 days of collection. For contraction 160 
studies, A. suum muscle flaps were prepared as described in Trailović et al. (2015). 161 
Briefly, an anterior part of the worm, 2-3 cm caudal to the head was dissected to prepare a 162 
1 cm muscle flap and the lateral line was removed from the edge of the flaps. Each muscle 163 
flap was attached to a force transducer in an experimental bath maintained at 37 °C, 164 
containing 20 mL Ascaris Perienteric Fluid Ringer (23 mM NaCl, 110 mM Na acetate, 165 
24 mM KCl, 6 mM CaCl2, 5 mM MgCl2, 11 mM glucose, 5 mM HEPES, pH 7.6) and 166 
bubbled with room air. The isometric contractions were monitored on a PC computer using 167 
a BioSmart interface with eLAB software (EIUnit, Belgrade). The preparations were 168 
allowed to equilibrate for 15 min under an initial tension of 0.5 g following 169 
which acetylcholine (1–100 µM) in the absence and presence of menthol (0.1 µM) was 170 
applied to the preparation. The responses for each concentration were expressed in grams 171 
(g).  172 
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 173 
2.4 Drug Applications 174 
Acetylcholine chloride, L-menthol, (-)-menthone, eugenol, (S)-(-)-β-Citronellol, (+)-175 
limonene oxide, carvacrol, ((R)-(-))-carvone, menthyl acetate, phenethyl propionate, trans-176 
cinnamaldehyde and BAPTA-AM were purchased from Sigma-Aldrich (St Louis, MO, 177 
USA). (+)-Pulegone was purchased from Kodak (Rochester, NY, USA) and geraniol from 178 
Berje (Carteret, NJ, USA). Acetylcholine was dissolved in recording solution while 179 
monoterpenoid compounds (Figure 1) were dissolved in DMSO such that the final working 180 
concentration did not exceed 0.1%. 181 
 182 
Oocytes were perfused with drugs by an 8-channel system (VC-8 valve controller) (Warner 183 
Instruments, USA) at a flow rate of ~6 mL/min.  For the agonist experiments, all the 184 
essential oils were used at a concentration of 100 µM. All the responses were normalized 185 
to the control (100 µM acetylcholine) response. Each drug was applied for 10s and the 186 
wash off time between each drug was 2 minutes. The application sequence of agonists for 187 
determining the potency series was random and not predetermined. The concentration-188 
response relationship for acetylcholine was generated by applying increasing 189 
concentrations of acetylcholine (0.1-300 µM) for 10 s.  190 
 191 
For positive allosteric modulator experiments, we tested the effects of menthol (0.1 and 10 192 
µM) on acetylcholine and levamisole concentration-response relationship. Control 193 
concentration-responses were obtained by applying ascending concentrations of the 194 
agonist for 10 s. Concentration-response relationships in the presence of 0.1 µM and 10 195 
µM menthol were generated by first applying a control 100 µM acetylcholine for 10 s, 196 
followed by a 2-min application of menthol, and 10 s applications of increasing 197 
concentrations of the agonist in the continued presence of menthol. The responses were 198 
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normalized to the control 100 µM acetylcholine current. Between each drug application a 199 
2 min wash off time was allowed, and the responses were normalized to the control 200 
100 µM acetylcholine current.  201 
 202 
In order to characterize the antagonist properties of the phytocompounds, a control 203 
concentration of 100 µM ACh was first applied for 30 s followed by a 2 min wash with 204 
recording solution. Thereafter, 100 µM acetylcholine was applied for 10 s, immediately 205 
followed by 10 s application of the antagonist (100 µM) in the continued presence of 100 206 
µM ACh and then a final 10 s application of 100 µM ACh. At least 2 min drug wash off 207 
interval was allowed between applications in order to minimize desensitization. Note that, 208 
the potency for each antagonist is likely to be slightly underestimated due to the short time 209 
of drug application with this approach (Abongwa et al., 2016a). Acetylcholine 210 
concentration-response relationships in the presence of 100 µM limonene oxide and 100 211 
µM carvacrol were generated by first applying a control 100 µM acetylcholine for 10 s, 212 
followed by a 2-min application of the antagonist, and 10 s applications of 3, 10, 30, 100 213 
and 300 µM acetylcholine in the continued presence of antagonist. The responses were 214 
normalized to the control 100 µM acetylcholine current. 215 
 216 
2.5 Data and statistical analysis  217 
Data acquired from electrophysiological recordings were analyzed with Clampfit 10.3 218 
(Molecular Devices, Sunnyvale, CA, USA) and GraphPad Prism 7.0 (Graphpad Software 219 
Inc., La Jolla, CA, USA). The peak current responses in oocytes to applied drugs were 220 
normalized to the 100 µM ACh control current (unless otherwise indicated) and expressed 221 
as mean ± SEM. All completed drug application sequences on the oocytes were used for 222 
analysis without exclusion. If the recording became unstable, indicated by a change in the 223 
baseline holding current, all of that recording was rejected for analysis. The mean % 224 
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inhibition produced by monoterpenoid compounds on currents elicited by 100 µM 225 
acetylcholine were calculated as previously described (Zheng et al., 2016). For A. suum 226 
contraction experiments, mean contraction responses in grams (g) to each concentration 227 
of acetylcholine in the absence and presence of menthol was determined. The sigmoidal 228 
concentration-responses for the oocytes experiments and isometric contraction studies 229 
were described using the following equation:  230 
% response= 1/1+[EC50/Xa]nH 231 
 where EC50 is the concentration of agonist (Xa) producing 50 % of the maximum 232 
response and nH is the Hill coefficient (slope). Differences in pEC50 and Imax were 233 
assessed using extra sum of squares F-test. Two-way ANOVA and paired t-tests were 234 
used to test differences between control contractions and test contractions on the same 235 
muscle flap. The difference was considered significant if P<0.05. 236 
 237 
3. RESULTS: 238 
3.1 Pharmacology of monoterpenoids on Ode (29-38-63-8) receptor 239 
3.1.1 Agonist pharmacology 240 
The agonist properties of 12 monoterpenoid compounds were investigated on the 241 
levamisole sensitive Ode-unc-29∶Ode-unc-38∶Ode-unc-63∶Ode-acr-8 nAChR (Figure 2). 242 
11 of the 12 monoterpenoids we tested showed no significant agonistic effect (<1.0% of 243 
control acetylcholine current; Figure 2A) on the expressed levamisole sensitive channel. 244 
Menthol was the only compound tested that produced an agonist effect, showing only ≈ 245 
6.5% of the control acetylcholine currents.  246 
 247 
3.1.2 Antagonist pharmacology 248 
We tested potential antagonistic effects of the same 12 monoterpenoids on the levamisole 249 
sensitive receptor (Figure 3). Among all the phytocompounds tested limonene oxide, 250 
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citronellol, carvone, carvacrol, pulegone and eugenol reduced the acetylcholine response. 251 
Limonene oxide was the most potent inhibitor (mean inhibition% = 36.0 ± 3.2%). The rank 252 
order potency of inhibition was: limonene oxide > citronellol > carvone > carvacrol = 253 
pulegone = eugenol (Figure 3A). Interestingly, monoterpenoids including menthol, 254 
menthone, menthyl acetate and geraniol increased the amplitude of currents produced by 255 
acetylcholine instead of inhibiting them (data not shown). Menthol produced the most 256 
potent positive allosteric modulation and increased the response by 3.1 ± 0.7% (mean ± 257 
SEM) with a maximum potentiation of 6.3%. 258 
 259 
3.1.3 Antagonistic effects of limonene oxide and carvacrol on acetylcholine concentration-260 
response relationship 261 
The concentration-response relationship for acetylcholine was examined by applying 262 
increasing concentrations of acetylcholine 0.3–300 µM to oocytes expressing the 263 
levamisole sensitive nAChR (Figure 3B & C). The sigmoidal concentration-response fit 264 
gave pEC50 = 5.3 ± 0.0 (EC50 = 5.3 µM), a hillslope (nH) of 2.0 ± 0.2 and Imax value of 104.6 265 
± 1.6%. We investigated the effects of limonene oxide (100 µM) and carvacrol (100 µM) on 266 
the acetylcholine concentration-response relationship. Imax for acetylcholine in the 267 
presence of limonene oxide and carvacrol were 62.8 ± 7.0% and 74.1 ± 3.2%, 268 
respectively. Both the monoterpenoid compounds produced a statistically significant 269 
reduction in the maximum response (P<0.001 for limonene oxide; P<0.0001 for carvacrol; 270 
Figure 3B & C). Neither carvacrol, pEC50 = 5.7 ± 0.1 (EC50 = 2.0 µM) nor limonene oxide, 271 
pEC50 = 5.4 ± 0.2 (EC50 = 4.0 µM) increased the EC50 values c.f. control. This indicates 272 
limonene oxide and carvacrol both produced non-competitive inhibition and are not binding 273 
at the agonist-binding site to produce their effect. 274 
 275 
3.1.4 Menthol as positive allosteric modulator  276 
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Menthol was a weak agonist on the expressed levamisole sensitive receptor. However, it 277 
appeared to potentiate acetylcholine responses in our antagonist experiments (data not 278 
shown). To investigate positive allosteric modulation further, we analyzed the effect of 279 
menthol on acetylcholine and levamisole concentration-response relationships (Figure 4 280 
and Figure 5). We observed a left shift in the sigmoidal concentration-response curves for 281 
both levamisole and acetylcholine in the presence of menthol. Sensitivity of the receptor 282 
was increased significantly for acetylcholine, pEC50 = 5.3 ± 0.0 (EC50 = 5.0 µM); in the 283 
presence of 0.1 µM menthol, pEC50 = 6.4 ± 0.1 (EC50 = 0.4 µM) and with 10 µM menthol, 284 
pEC50 = 6.5 ± 0.1 (EC50 = 0.3 µM).  285 
For levamisole alone, pEC50 and EC50 values were 6.3 ± 0.1 and 0.5 µM respectively. In 286 
the presence of 0.1 µM menthol pEC50 and EC50 values were 6.5 ± 0.1 and 0.3 µM 287 
respectively. In the presence of 10 µM menthol the pEC50 and EC50 values were 6.8 ± 0.2 288 
and 0.2 µM. Only 10 µM menthol produced a significant left shift in the levamisole 289 
concentration-response curve (P<0.05; Figure 5C). The positive allosteric modulation 290 
produced by menthol was more pronounced with acetylcholine as an agonist in 291 
comparison to levamisole. In conclusion, menthol not only acts as an agonist on the 292 
levamisole sensitive receptor but also displays significant PAM activity on this nAChR.  293 
  294 
3.2 Effects of menthol and carvacrol on A. suum ACR-16 nAChR 295 
Figure 6 shows the concentration-response relationship for acetylcholine on the expressed 296 
Asu-ACR-16 nicotine sensitive nAChR. The sigmoidal concentration-response fit gave 297 
pEC50 = 5.0 ± 0.1 (EC50 = 11.1 µM), Imax = 109.1 ± 6.6% and a hillslope (nH) of 1.6 ± 0.3. 298 
We investigated the effects of menthol (10 µM) and carvacrol (10 µM and 100 µM) on the 299 
acetylcholine response. There was no significant change in the sensitivity or efficacy of 300 
acetylcholine on the N-type receptor in the presence of menthol (pEC50 = 5.0 ± 0.1 and I max 301 
=101.6 ± 7.5%). The concentration-response fits (Figure 6C) show that 100 µM carvacrol 302 
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decreased the maximum response while 10 µM carvacrol failed to exhibit any significant 303 
antagonistic properties. In the presence of 10 µM carvacrol pEC50, EC50 and Imax values 304 
were 5.1 ± 0.1, 8.1 µM and 94.6 ± 5.9% respectively. Carvacrol produced a significant 305 
reduction in Imax (55.8 ± 4.4%; P<0.05) when applied at 100 µM concentration but did not 306 
produce a significant right shift in the pEC50 (5.1 ± 0.1). This indicates carvacrol at 100 µM 307 
produced non-competitive inhibition.  308 
 309 
3.3 Effect of menthol on A. suum muscle  310 
We examined the effect of menthol on the A. suum muscle flap contractions induced by 311 
increasing concentrations of acetylcholine. Figure 7A shows the representative trace for 312 
acetylcholine, in the absence and presence of 0.1 µM menthol in the experimental bath. 313 
Acetylcholine produced concentration-dependent isometric contractions with a pEC50 of 314 
5.2 ± 0.2 (EC50 = 7.0 µM) and Rmax = 1.7 ± 0.2 g. We did not observe a significant left shift 315 
in pEC50 (5.2 ± 0.2) or change in Rmax (2.0 ± 0.2 g) in the presence of menthol. As 316 
expected, based on two-way ANOVA, acetylcholine concentration had a significant effect 317 
on muscle contraction (P<0.0001). Importantly the presence of menthol also had a 318 
significant effect on muscle contraction (P<0.0001). Further analysis revealed a significant 319 
potentiation of contractions at each concentration of acetylcholine in the presence of 320 
menthol (paired t-tests, P<0.05, Figure 7B for examples). This modulatory effect of 321 
menthol is similar to our observed effects on the levamisole sensitive receptor.  322 
 323 
4. DISCUSSION: 324 
Monoterpenoids are a group of plant secondary metabolites that have been shown to 325 
modulate the function of nicotinic acetylcholine receptors of mammals and insects (Lozon 326 
et al., 2016; Park et al., 2003; Park et al., 2001; Tong et al., 2013). We were interested in 327 
finding possible agonists, antagonists or modulators for these cys loop receptors of 328 
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parasitic nematodes. In this study, we provide evidence of significant modulatory effects of 329 
several monoterpenoid compounds on the levamisole sensitive O. dentatum receptor and 330 
nicotine sensitive A. suum nAChR. We chose to use the levamisole sensitive nAChR from 331 
O. dentatum due to unreliable expression of the levamisole sensitive nAChR from A. suum 332 
in our hands. 333 
 334 
The majority of the phytocompounds tested failed to exhibit agonist properties on the 335 
nAChRs but we were able to identify inhibitors of the levamisole sensitive nematode 336 
receptor with a rank order:    337 
limonene oxide > citronellol > carvone > carvacrol = pulegone = eugenol. 338 
Limonene oxide and carvacrol produced significant non-competitive inhibition suggesting 339 
neither compound acts at the ligand binding sites. Limonene oxide is a monoterpene found 340 
in essential oils of various citrus fruits and is an odorous component of some types of 341 
mushrooms (Breheret et al., 1997; Lemes et al., 2018; Lota et al., 2002; Rapior et al., 342 
1997; Vieira et al., 2018); it has been reported to stimulate TRPA1 cation channels 343 
(Kaimoto et al., 2016). There are limited data available on the effects of limonene oxide on 344 
nAChRs and this is the first example of an antagonistic effect of the compound on a 345 
levamisole sensitive nematode nAChR. According to a study done by Kim et al. (2013) 346 
limonene oxide was reported to be a safe phytochemical in mammals and thus could be 347 
used in combination with other nicotinic inhibitors for anti-nematodal therapy. Carvacrol, 348 
found in many plants (thyme, oregano, Alaska yellow cedar; (Bouchra et al., 2003; De 349 
Vincenzi et al., 2004) acted as a non-competitive inhibitor on both levamisole sensitive and 350 
nicotine sensitive nematode receptors. Various studies have shown alpha-7 homomeric 351 
nAChRs, GABA (gamma amino-butyric acid) and tyramine receptors as target sites for 352 
carvacrol (Lozon et al., 2016; Tong and Coats, 2012; Tong et al., 2013). In addition, 353 
carvacrol was shown to produce significant inhibitory effects on acetylcholine induced 354 
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muscle contractions in A. suum (Trailović et al., 2015). This polypharmacological effect of 355 
carvacrol might make it efficacious as an anthelmintic phytotherapeutic, although it may be 356 
best considered as an adjunct to other anti-nematodal compounds to increase efficacy due 357 
to toxicity considerations when used alone at high concentrations (Bimczok et al., 2008; 358 
Roselli et al., 2007; Stammati et al., 1999). 359 
 360 
The most interesting finding was the positive allosteric modulatory activity of menthol on 361 
the levamisole sensitive nematode nAChR. Menthol is a monocyclic terpene alcohol 362 
extracted from peppermint plants, Mentha spp. and regulates somatosensory sensations 363 
such as warmth, pain and irritation (Cliff and Green, 1994; Eccles, 1994; Farco and 364 
Grundmann, 2013). Menthol showed very mild agonist activity but produced statistically 365 
significant potentiation of acetylcholine induced inward currents at concentrations as low 366 
as 0.1 µM and of levamisole induced currents at 10 µM on the levamisole sensitive cation 367 
channel. PAM compounds exhibit potentiation of the agonist-activation effects by binding 368 
to a site distinct from the ligand binding sites. This property is highly desired in drug 369 
discovery and development as PAMs can achieve subtype selectivity more easily in 370 
comparison to compounds binding to orthosteric sites (Chatzidaki and Millar, 2015; 371 
Williams et al., 2011) as all the nAChRs have highly conserved acetylcholine binding sites. 372 
In comparison, the conservation for amino acid composition for other sites is less which 373 
makes PAMs preferable in terms of selectivity and reduced potential off target effects 374 
(Chatzidaki and Millar, 2015; Williams et al., 2011).  Menthol modulates the 375 
pharmacological properties and expression of vertebrate nicotinic acetylcholine receptors; 376 
it inhibits the effect of nicotine on α7-nACh receptors in neural cells in a non-competitive 377 
manner (Ashoor et al., 2013; Hans et al., 2012; Ton et al., 2015). However, it is worth 378 
noting that these negative allosteric modulatory and inhibitory effects of menthol on α7-379 
nACh receptors were produced by much higher concentrations (30-300 µM) in comparison 380 
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to our study. In addition, menthol at 10 µM had no significant effect on the nematode 381 
nicotine sensitive nAChR (the closest ortholog to vertebrate α7-nAChRs in the 382 
nematodes). This makes menthol an interesting candidate that can potentiate the effects 383 
of cholinergic agonist anthelmintics acting on levamisole sensitive nAChRs. Importantly, 384 
0.1 µM menthol produced significant potentiation of contractions produced by 385 
acetylcholine on A. suum muscle flaps.  The presence of positive allosteric modulation in 386 
the somatic muscle flap preparation can be attributed to the presence of levamisole 387 
receptors and is important in vivo confirmation of our findings from the in vitro 388 
heterologous expression studies. 389 
 390 
5. Conclusion 391 
Natural products have formed the basis of sophisticated traditional therapies and they 392 
continue to play essential roles in modern healthcare. Phytocompounds, with their 393 
complex chemistry and structural diversity, offer the potential for discovery and 394 
development of new pharmaceuticals. Botanical anthelmintics may reduce the need for 395 
chemical drug treatment and alleviate the pressure on the limited group of anthelmintics 396 
available. Carvacrol produced significant antagonism on the acetylcholine induced inward 397 
currents on both levamisole sensitive and nicotine sensitive nematode ligand gated ion 398 
channels. This illustrates a multifaceted mode of action with involvement of multiple target 399 
subtypes that can help ameliorate the issue of drug resistance. It may be possible to 400 
combine these compounds with the nAChR antagonist derquantel or perhaps with a 401 
macrocyclic lactone as with Startect® (derquantel + abamectin). 402 
 403 
Our results provide promising evidence of positive allosteric modulation by menthol which 404 
could be used in combination therapy with cholinomimetic drugs like pyrantel or levamisole 405 
to increase efficacy. For future investigations menthol could be used as the starting point 406 
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in structure activity relationship studies to find new potent PAM compounds suitable for 407 
stand-alone use as anthelmintics.  In summary, the use of plant derived compounds, either 408 
alone or in combination, could facilitate sustainable control of parasitic nematodes. The 409 
results of the present study are encouraging and suggest monoterpenoids can be 410 
exploited as components of new anthelmintic formulations. 411 
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 639 
Figure Legends: 640 
Figure 1: Chemical structures of monoterpenoid compounds used in the present study. 641 
 642 
Figure 2: Agonist effects of monoterpenoid compounds on levamisole sensitive O. 643 
dentatum nAChR. A. Sample traces for the agonist experiment. B. Bar chart (expressed 644 
as mean ± SEM%) showing agonistic effects of the monoterpenoid compounds: menthol 645 
(6.5 ± 2.4%, n = 6), geraniol (0.9 ± 0.2%, n = 6), cinnamaldehyde (0.6 ± 0.2%, n = 6), 646 
citronellol (0.4 ± 0.2%, n = 6), menthyl acetate (0.3 ± 0.1%, n = 6), eugenol (0.3 ± 0.2%, n 647 
= 6), phenethyl propionate (0.3 ± 0.1%, n = 6), limonene oxide (0.3 ± 0.2%, n = 6), 648 
carvacrol (0.2 ± 0.2%, n = 6), menthone (0.2 ± 0.1%, n = 6), pulegone (0.1 ± 0.1%, n = 6) 649 
and carvone (0.0 ± 0.0%, n = 6).  650 
 651 
Figure 3: Effect of monoterpenoid compounds as antagonists on levamisole sensitive O. 652 
dentatum receptor acetylcholine mediated responses. A. Bar graph showing the rank order 653 
potency of monoterpenoid compounds as antagonists. Results were expressed as % 654 
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mean inhibition ± SEM of currents elicited by 100 µM ACh: limonene oxide (36.0 ± 3.2%, n 655 
= 6) > citronellol (18.0 ± 1.6%, n = 6) > carvone (14.0 ± 0.6%, n = 6) > carvacrol (11.0 ± 656 
1.6%, n = 6) = pulegone (11.0 ± 2.6%, n = 6) = eugenol (11.0 ± 1.0 %, n = 6).  Inset: image 657 
showing predicted acetylcholine response in the absence of limonene oxide (dotted line) 658 
and inhibition of acetylcholine mediated response in the presence of limonene oxide 659 
(highlighted in green).  B. Acetylcholine current responses, recorded from the Xenopus 660 
oocyte expressing the levamisole sensitive channel, alone and in the presence of 100µM 661 
carvacrol (n=6) & 100 µM limonene oxide (n = 5). C. Concentration-response plots for 662 
acetylcholine alone (n = 6, black) and acetylcholine in the presence of 100 µM carvacrol (n 663 
= 6, maroon) & 100 µM limonene oxide (n = 5, green). pEC50 (mean ± SEM), EC50 (mean, 664 
µM), Hill slope (nH) (mean ± SEM) and Imax (mean ± SEM%) values were respectively: 5.3 665 
± 0.0, 5.3 µM, 2.0 ± 0.2 and 104.6 ± 1.6 for acetylcholine alone; 5.4 ± 0.2, 4.0 µM, 2.2 ± 666 
1.7 and 62.8 ± 7.0 in the presence of limonene oxide; 5.7 ± 0.1, 2.0 µM, 1.7 ± 1.1 and 74.1 667 
± 3.2 in the presence of carvacrol. Bottom was constrained to zero for curve fitting. 668 
 669 
Figure 4: Effects of menthol as a PAM on levamisole sensitive O. dentatum nAChR 670 
acetylcholine responses. A. Sample traces (above) for two-electrode voltage-clamp 671 
recording showing inward currents in response to ascending concentrations of 672 
acetylcholine alone, acetylcholine in the presence of 0.1 µM and 10 µM menthol. B. 673 
Concentration-response relationships for acetylcholine alone (n = 7, black), acetylcholine 674 
in the presence of 0.1 µM (n = 6, blue) and 10 µM menthol (n=7, purple). pEC50 (mean ± 675 
SEM), EC50 (mean, µM), Hill slope (nH) (mean ± SEM) and Imax (mean ± SEM%) values 676 
were respectively: 5.3 ± 0.0, 5.0 µM, 1.4 ± 0.1 and 107.5 ± 2.6 for acetylcholine alone; 6.4 677 
± 0.1, 0.4 µM, 1.0 ± 0.1 and 109.0 ± 3.6 in the presence of 0.1 µM menthol; 6.5 ± 0.1, 0.3 678 
µM, 1.0 ± 0.1 and 110.5 ± 3.7 in the presence of 10 µM menthol. Bottom was constrained 679 
to zero for curve fitting. C. Bar chart showing comparison of pEC50 (expressed as mean ± 680 
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SEM) for acetylcholine in the presence and absence of menthol. ****P<0.0001; 681 
significantly different as indicated; extra sum of squares F-test. 682 
 683 
Figure 5: Effects of menthol on levamisole sensitive nAChR levamisole responses. A. 684 
Representative current traces for two-electrode voltage-clamp recording showing inward 685 
currents in response to ascending application of levamisole alone, levamisole in the 686 
presence of 0.1 µM and 10 µM menthol. B. Concentration-response relationships for 687 
levamisole alone (n = 7, steel gray) and in the presence of 0.1 µM (n = 6, light green) and 688 
10 µM menthol (n=7, dark green). pEC50 (mean ± SEM), EC50 (mean, µM), Hill slope (nH) 689 
(mean ± SEM) and Imax (mean ± SEM%) values were respectively: 6.3 ± 0.1, 0.5 µM, 1.0 ± 690 
0.2 and 96.3 ± 5.2 for levamisole alone; 6.5 ± 0.1, 0.3 µM, 1.1 ± 0.2 and 94.6 ± 5.0 in the 691 
presence of 0.1 µM menthol; 6.8 ± 0.2, 0.2 µM, 1.0 ± 0.2 and 89.2 ± 6.0 in the presence of 692 
10 µM menthol. Bottom was constrained to zero for curve fitting. C. Bar chart summarizing 693 
the results showing comparison of pEC50 (expressed as mean ± SEM) for levamisole in 694 
the presence and absence of menthol. *P<0.05; significantly different as indicated; extra 695 
sum of squares F-test. 696 
 697 
Figure 6: Effects of menthol and carvacrol on nicotine sensitive A. suum ACR-16 nAChR 698 
acetylcholine responses. A. Representative current traces for two-electrode voltage-clamp 699 
recording showing inward currents in response to increasing acetylcholine concentrations 700 
in the presence of menthol (10 µM) and carvacrol (10 µM and 100 µM) B. Concentration-701 
response plot for acetylcholine alone (n = 7, black) and acetylcholione in the presence of 702 
menthol (n = 6, red). pEC50 (mean ± SEM) and EC50 (mean, µM) values were respectively: 703 
5.0 ± 0.1 and 11.1 µM for acetylcholine alone, 5.0 ± 0.1 and 9.5 µM in the presence of 10 704 
µM menthol. Hill slope (nH) (mean ± SEM) values were: 1.6 ± 0.3 for acetylcholine alone; 705 
2.5 ± 1.2 in the presence of 10 µM menthol. Imax (mean ± SEM%) values were: 109.1 ± 6.6 706 
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for acetylcholine alone; 101.6 ± 7.5 in the presence of 10 µM menthol. Bottom was 707 
constrained to zero for curve fitting. C. Concentration-response plots for acetylcholine 708 
alone (n = 7, black) and in the presence of carvacrol (n=6, blue). pEC50 (mean ± SEM), 709 
EC50 (mean, µM), Hill slope (nH) (mean ± SEM) and Imax (mean ± SEM%) values were 710 
respectively: 5.1 ± 0.1, 8.1 µM, 2.5 ± 0.8 and 94.6 ± 5.9 in the presence of 10 µM 711 
carvacrol, 5.1 ± 0.1, 8.2 µM, 2.0 ± 0.7 and 55.8 ± 4.4 in the presence of 100 µM carvacrol. 712 
Bottom was constrained to zero for curve fitting.   713 
 714 
Figure 7: A. Sample trace for the A. suum muscle flap contraction experiments. Inset: 715 
concentration-response plots for acetylcholine alone (n = 6, black) and in the presence of 716 
0.1 µM menthol (n = 6, red). pEC50 (mean ± SEM) and EC50 (mean, µM) values were 717 
respectively: 5.2 ± 0.2 and 7.0 µM for acetylcholine alone; 5.2 ± 0.2 and 6.5 µM in the 718 
presence of 0.1 µM menthol. Rmax (mean± SEM, g) values were: 1.7 ± 0.2 g for 719 
acetylcholine alone and 2.0 ± 0.2 g in the presence of 0.1 µM menthol. Hill slope (nH) 720 
(mean ± SEM) values were: 0.8 ± 0.2 for acetylcholine alone and 0.8 ± 0.1 in the presence 721 
of 0.1 µM menthol. Bottom was constrained to zero for curve fitting.  B. Bar chart 722 
summarizing the results showing significant potentiation in amplitude of acetylcholine 723 
mediated contractions in the presence of 0.1 µM menthol. *P<0.05, ***P<0.001; 724 
significantly different as indicated; paired t-tests. 725 
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Highlights 1 
• We screened 12 monoterpenoid compounds to search for a potential 2 
anthelmintic. 3 
• Menthol acted as PAM on levamisole sensitive nematode nAChRs in vitro & in 4 
vivo. 5 
• Carvacrol produced antagonism on both levamisole and nicotine sensitive 6 
nAChRs. 7 
• Monoterpenoid compounds can be used as an adjunct with cholinergic 8 
anthelmintics. 9 
